Arthrocentesis in the Management of Temporomandibular Joint Disorders: Current and Innovative Approaches

Creative Commons License

Duman B., Gedik B., Bokhari S. A. H., DOĞANCALI DEMİRAL G. E., ERDEM M. A.

European Journal of General Dentistry, 2026 (Scopus)

Özet

Temporomandibular joint disorders (TMDs) affect a substantial proportion of the population and represent the second most common musculoskeletal complaint after chronic low back pain. Arthrocentesis has emerged as an effective, minimally invasive, and cost-efficient treatment option for patients who do not respond adequately to conservative therapies such as nonsteroidal anti-inflammatory drugs, physiotherapy, and occlusal splints. Since its first description by Nitzan in 1991, both the technical aspects of arthrocentesis and the range of intra-articular agents used in conjunction with lavage have evolved considerably. Recent developments include single-needle and modified techniques, image-guided and navigation-assisted approaches, and the use of orthobiologic agents such as platelet concentrates and bone marrow-derived products. This narrative review summarizes contemporary diagnostic imaging and functional assessment methods, modern conservative treatment modalities, current arthrocentesis techniques, and up-to-date evidence on intra-articular pharmacologic and biologic agents. In addition, a pragmatic clinical decision-making framework is outlined to situate arthrocentesis within a stepwise management algorithm for TMDs. Overall, current data support arthrocentesis as a safe and effective option in selected patients; however, heterogeneity in techniques and injection protocols underscores the need for well-designed randomized controlled trials to establish standardized, patient-specific treatment pathways.